Ibrahim Hussain Alzahib

Resmetirom and New Agents for Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review of Phase 3 Data on Histologic and Clinical Outcomes

Ibrahim Hussain Alzahib, Ensaf Adnan Mousa AlBokhari, Khalid Hazim A. Alotaibi, Mashael Zayed M. AlBalawi, Bader Abdulrahman Husayyan Alanazi, Metab Ali Saeed Alasmari, Mohammed Hussain Abdulrahman Alzahib & Norah Saad Jubran Alkahtani · International Research Journal of Gastroenterology and Hepatology · 2026

Background: Metabolic dysfunction-associated steatohepatitis (MASH), formerly termed nonalcoholic steatohepatitis, can progress to advanced fibrosis, cirrhosis, hepatic decompensation, hepatocellular carcinoma, transplantation, and death. Resmetirom and semaglutide have reached c...